Patrick CallaghanAssociateMcDermott Will & Emery Websitewww.mwe.comOrganization ProfileFull ProfileBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn312 984 3641 Professional Biography Patrick Callaghan is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. He focuses his practice on health law matters. More Legal and Business Bylines From Patrick Callaghan CMS Final Rule Overhauls Long-Term Care Facility Regulations & Federal Court Blocks Enforcement of Key Provision - (Posted On Friday, December 16, 2016) Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program - (Posted On Monday, November 14, 2016) CMS Increase in Mandated Nursing Facility Civil Monetary Penalties - (Posted On Tuesday, September 13, 2016) Office for Civil Rights (OCR) to Begin Phase 2 of HIPAA Audit Program - (Posted On Tuesday, July 29, 2014) Current Legal Analysis USCIS Announces Initial FY 2026 H-1B Cap Selection: What Employers Need to Do Next by: Jessica K. Lang SEC Provides Further Clarity in Rule 506(c) Offerings by: Daniel I. DeWolf , Samuel Asher Effron FedRAMP 20x – Major Overhaul Announced to Streamline the Security Authorization Process for Government Cloud Offerings by: Townsend L. Bourne , Daniel J. Alvarado USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program by: Lynn L. Bergeson , Carla N. Hutton Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers by: Lotan Barbaresso , Amy J. Dilcher The Third Time’s A Charm: Colorado Adds Nuclear Energy as a Clean Energy Resource by: Thomas J. Dougherty SEC Policy Shift and Recent Corp Fin Updates – Part 1 by: Julie F. Rizzo , Linsey N. Taulbee Corporate Transparency Act Update: Drastic Reduction in Scope of BOI Reporting in March 21, 2025 FinCEN Guidance by: Jonathan F.X. O’Brien USPTO Implements Bifurcated Review Process for Patent Petitions Under New Policy by: Preston H. Heard , Kyle W. Kellar Trump Administration Efforts to Eliminate Cartels Pose Heightened Risk for Financial Institutions by: Seth D. DuCharme GLP-1 Receptor Agonists: Drug Litigation Overview and Trends by: Liane M. Peterson Supreme Court Declines Review of “Relational Analysis” for Determining Administrative Exemption by: Michael Reed Kentucky Legislature Ends Judicial Deference To State Agencies by: Stephen P. Kranz , Michael J. Hilkin VHA and DLA Enter Into Another Interagency Agreement: Déjà Vu All Over Again? by: Merle M. DeLancey Jr. When Is Conduct ‘Primarily and Substantially’ in Massachusetts Under Chapter 93A? by: David G. Thomas , Angela C. Bunnell Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 7 2025 Understanding the Basics of a Class Action Print
